Conditions: Diabetes Mellitus, Type 2
Keywords: Type 2 Diabetes Mellitus Pharmacodynamics Safety & Tolerability
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 19
Healthy volunteers: no

Brief summary:
This study is designed to assess the safety, tolerability and pharmacodynamics of 6 weeks of oral doses of PF-05175157 provided as monotherapy in subjects with type 2 diabetes mellitus.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: PF-05175157 intervention 2: Placebo
Intervention descriptions: intervention 1: PF-05175157 will be administered at 200 mg twice a day for 43 days. intervention 2: Placebo tablets matched to PF-05175157 will be administered twice a day for 43 days.

Protocol document: